10 results
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... Non-Opioid Analgesics - Agents ... #Pain #Pharmacology ... #NonOpioid #Analgesics ... #Medications #Doses
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... Medications: ... Agent, Initiation ... #Pain #Pharmacology ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... Muscle Relaxants - Agents ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... Distribution, Agents ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Doses #Dosing
In 2018, opioid withdrawal should be considered a buprenorphine deficiency. Otherwise, a multitude of comparatively ineffective
opioid withdrawal should ... in high enough doses ... @emupdates #Management ... #Pharmacology # ... Pain #NonOpioid
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... - Agents and Dosing ... #Management # ... Pain #Pharmacology ... #Doses #Dosing
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Anti-IL6 Agents ... Total dose should ... Tocilizumab should ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
getting patients on medication ... with HFrEF, we should ... to the target dose ... HeartFailure #HFrEF #Pharmacology ... #Management #Treatment
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
extubation, as it should ... non-OTC prolonging agent ... No pharmacologic ... (Haldol) - No pharmacologic ... CriticalCare #diagnosis #management
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
polyuria, weight gain ... Lithium is a medication ... a maintenance agent ... lithium level, you should ... BPD #Toxicity #Pharmacology